fingolimod

Italy

Drugs containing this active substance

  • FINGOLIMOD ACCORD

    It is used for the treatment of relapsing-remitting multiple sclerosis (RRMS) in adults and children/adolescents (from 10 years of age onwards), particularly for those who have not responded to other therapies or for those with a severe, rapidly progressing form. It does not cure the disease, but it helps to reduce relapses and slow the progression of physical disability.

    Form: capsules, hard gelatin

    Active substance Dosage
    fingolimod -

    ATC: L04AE01

    Manufacturer: ACCORD HEALTHCARE, S.L.U.

  • It is used in adults, adolescents, and children from 10 years of age (weighing more than 40 kg) for the treatment of relapsing-remitting multiple sclerosis (RRMS), particularly for those who have not responded to other therapies or for those with a severe, rapidly progressing form. It does not cure the disease, but it helps to reduce relapses and slow the progression of physical disability.

    Form: capsules, hard gelatin

    Active substance Dosage
    fingolimod -

    ATC: L04AE01

    Manufacturer: EG S.P.A.

  • It is used in adults and children and adolescents (from 10 years of age and older) for the treatment of relapsing-remitting multiple sclerosis (RRMS), particularly for patients who have not responded to other therapies or for those with a severe, rapidly progressing form. It does not cure the disease, but it helps to reduce relapses and slow the progression of physical disability.

    Form: capsules, hard gelatin

    Active substance Dosage
    fingolimod -

    ATC: L04AE01

    Manufacturer: HCS BV

  • It is used for the treatment of relapsing-remitting multiple sclerosis (RRMS) in adults and children and adolescents aged 10 years and older, particularly for those who have not responded to other therapies or for those with a severe, rapidly progressing form. It helps to reduce relapses and slow the progression of physical disability.

    Form: capsules, hard gelatin

    Active substance Dosage
    fingolimod -

    ATC: L04AE01

    Manufacturer: TILLOMED ITALIA SRL

  • Gilenya is used in adults and children and adolescents (from 10 years of age and older) to treat relapsing-remitting multiple sclerosis (RRMS), particularly for patients who have not responded to other therapies or who have a severe, rapidly progressing form. The drug helps to reduce the number of relapses and slow the progression of physical disability.

    Form: capsules, hard gelatin

    Active substance Dosage
    fingolimod -

    ATC: L04AE01

    Manufacturer: NOVARTIS EUROPHARM LIMITED